-
Soft Tissue Scaffolds in Breast Reconstruction: Evolution from Acellular Dermal Matrices to Synthetic Polymers -
Preclinical Rheumatoid Arthritis: Pathogenesis, Risk Stratification, and Therapeutic Interception -
Cardiac Involvement in Emery–Dreifuss Muscular Dystrophy, from Arrhythmias to Heart Failure and Sudden Death: A Contemporary Review -
Adherence to CPAP in Randomized Controlled Trials in Obstructive Sleep Apnoea—A Meta-Analysis and Investigation of Predictors -
Navigating the Hemostatic Balance: Anticoagulation and Antiplatelet Therapy in Patients with Thrombocytopenia
Journal Description
Journal of Clinical Medicine
Journal of Clinical Medicine
is an international, peer-reviewed, open access journal of clinical medicine, published semimonthly online by MDPI. The International Bone Research Association (IBRA), Spanish Society of Hematology and Hemotherapy (SEHH), Japan Association for Clinical Engineers (JACE), European Independent Foundation in Angiology/ Vascular Medicine (VAS) and others are all affiliated with JCM, and their members receive a discount on article processing charges.
- Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
- High Visibility: indexed within Scopus, SCIE (Web of Science), PubMed, PMC, Embase, CAPlus / SciFinder, and other databases.
- Journal Rank: JCR - Q1 (Medicine, General and Internal) / CiteScore - Q1 (General Medicine)
- Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 18.5 days after submission; acceptance to publication is undertaken in 2.7 days (median values for papers published in this journal in the second half of 2025).
- Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
- Companion journals for JCM include: Epidemiologia, Transplantology, Uro, Sinusitis, Rheumato, Journal of Clinical & Translational Ophthalmology, Journal of Vascular Diseases, Osteology, Complications, Therapeutics, Sclerosis, Pharmacoepidemiology, Journal of CardioRenal Medicine and Rare Diseases and Therapeutics.
- Journal Clusters of Hematology: Hemato, Hematology Reports, Thalassemia Reports and Journal of Clinical Medicine.
Impact Factor:
2.9 (2024);
5-Year Impact Factor:
3.3 (2024)
Latest Articles
Plasma Albumin Changes During Admission for Bloodstream Infection as Prognostic Predictors After Discharge—A Population-Based Cohort Study
J. Clin. Med. 2026, 15(11), 4329; https://doi.org/10.3390/jcm15114329 (registering DOI) - 3 Jun 2026
Abstract
Background: With a half-life of 18–20 days, rapid declines in plasma albumin (PA) levels may reflect increased vascular loss of PA, e.g., as seen with inflammatory insults. Methods: Our study included 11,562 adult patients with first-time bloodstream infection (BSI) in a geographically well-defined
[...] Read more.
Background: With a half-life of 18–20 days, rapid declines in plasma albumin (PA) levels may reflect increased vascular loss of PA, e.g., as seen with inflammatory insults. Methods: Our study included 11,562 adult patients with first-time bloodstream infection (BSI) in a geographically well-defined Danish region between 2007 and 2016, all with ≥2 PA specimens during BSI admission and discharged alive from the hospital. We assessed mortality 1–30, 31–90, 91–365, and >365 days after discharge. Predictors were the BSI admission’s first or last PA specimen’s level, grouped into <25, 25–34, and ≥35 g/L as well as combinations of these (reflecting changes [none, increase, or decrease]). We applied Cox’s regression analyses for a baseline model with age, sex, comorbidity, and BSI microorganisms as well as the baseline model with amendments of the first, last, or change in the PA levels. We further computed areas under the ROC curves (AUROCs) to assess how much the PA covariates changed AUROCs for the baseline model. Results: The last PA group and the changes between the first and the last PA group were the strongest predictors, with little differences between these. Lower PA level groups predicted higher mortality, especially up to 90 days. For 1–30 day mortality, the hazard ratio was 3.69 for the last PA group of <25 g/L and 0.31 for ≥35 g/L (reference: 25–34 g/L). AUROCs for the baseline model were 0.72 for the 1–30 and 0.73 for the 31–90-day mortality whereas the amendment of the PA changes increased these areas to 0.79 and 0.76, respectively. Higher AUROCs (range 0.83–0.90) were seen in non-comorbid patients, in patients aged <65 years, and in the lower quartile of days between the first and the last PA specimen. Conclusions: The BSI admission’s last PA specimen was a strong mortality predictor, especially up to 90 days. Higher AUROCs were found in younger, non-comorbid patients, and in patients with higher velocity of the PA changes. These results corroborate that hypoalbuminemia is mainly a marker of acute events.
Full article
(This article belongs to the Special Issue State-of-the-Art Advances in Bloodstream Infections)
►
Show Figures
Open AccessArticle
Long-Term Results of a Comparison Between 15 × 2.633 Gy and 20 × 2.0 Gy for Malignant Spinal Cord Compression in Patients with Longer Expected Survival Times
by
Dirk Rades, Christian Staackmann, Darejan Lomidze, Barbara Segedin, Blaz Groselj, Fernando Lopez Campos, Arturo Navarro-Martin and Jon Cacicedo
J. Clin. Med. 2026, 15(11), 4328; https://doi.org/10.3390/jcm15114328 (registering DOI) - 3 Jun 2026
Abstract
Background/Objectives: A considerable number of patients with malignant spinal cord compression (MSCC) and a longer expected lifespan do not receive upfront surgery but radiation therapy alone. These patients were suggested to benefit from radiation programs with total doses > 30 Gy in terms
[...] Read more.
Background/Objectives: A considerable number of patients with malignant spinal cord compression (MSCC) and a longer expected lifespan do not receive upfront surgery but radiation therapy alone. These patients were suggested to benefit from radiation programs with total doses > 30 Gy in terms of better local progression-free survival (LPFS). A previous study compared such regimens, namely 15 × 2.633 Gy over three weeks (34 patients, prospective cohort) and 20 × 2.0 Gy over four weeks (239 patients, control), using a propensity score-adjusted approach. Both regimens were associated with similar rates of overall survival (OS) and LPFS. However, follow-up was limited to 12 months. For long-term survivors, a longer period of follow-up would be desirable. Therefore, the present study was initiated. Methods: Retrospective collection of additional data enabled us to provide OS- and LPFS-rates at 36 months following radiation therapy. Results: In the prospective cohort, 36-month rates of OS and LPFS were 27.0% and 89.7%, respectively. After application of the propensity score-adjusted Cox regression model, 36-month OS-rates (HR 1.454; 95% CI 0.748–2.828; p = 0.270) and LPFS-rates (HR 0.311; 95% CI 0.041–2.352; p = 0.258) appeared not considerably different. Late radiation myelopathy and pathologic vertebral fractures were not identified. Conclusions: The results of the current study suggest that the role of 15 × 2.633 Gy should be further investigated in selected patients with MSCC, particularly when considering its shorter overall treatment time in comparison to 20 × 2.0 Gy. Overall, our findings are hypothesis-generating rather than confirmatory.
Full article
(This article belongs to the Special Issue Clinical Advances in Radiation Therapy for Cancers)
►▼
Show Figures

Figure 1
Open AccessArticle
Prognostic Value of the Cholesterol, High-Density Lipoprotein, and Glucose Index and Remnant Cholesterol Inflammatory Index in Young Patients with Acute Ischemic Stroke
by
Jiaokun Jia, Yuliang Qin, Jiahuan Guo, Xingquan Zhao and Yanfang Liu
J. Clin. Med. 2026, 15(11), 4327; https://doi.org/10.3390/jcm15114327 (registering DOI) - 3 Jun 2026
Abstract
Background: Young stroke (age ≤ 45) is a growing global health concern often driven by metabolic factors, with insulin resistance (IR) and dyslipidemia being key contributors. Novel metabolic indices, the Cholesterol–High-Density Lipoprotein–Glucose (CHG) index and the Remnant Cholesterol Inflammatory Index (RCII), have
[...] Read more.
Background: Young stroke (age ≤ 45) is a growing global health concern often driven by metabolic factors, with insulin resistance (IR) and dyslipidemia being key contributors. Novel metabolic indices, the Cholesterol–High-Density Lipoprotein–Glucose (CHG) index and the Remnant Cholesterol Inflammatory Index (RCII), have emerged as promising tools, yet their prognostic value in young stroke populations remains unexplored. Methods: We retrospectively analyzed 541 young stroke patients (age ≤ 45 years) between January 2019 and December 2021. The associations between CHG and RCII indices and poor functional outcomes at 90 days and discharge, infarct size, and hemorrhagic transformation were evaluated using multivariate logistic regression, restricted cubic spline (RCS) analysis, and receiver operating characteristic (ROC) curves. Subgroup, interaction, and sensitivity analyses were performed to assess the stability and robustness of the findings. Results: A total of 541 young stroke patients were included (median age 37 years). Patients with poor 90-day functional outcome (modified Rankin Scale ≥ 2) exhibited significantly higher CHG (5.2 vs. 5.1, p = 0.018) and RCII (2.8 vs. 1.7, p < 0.001) levels. After multivariable adjustment, both indices were independently associated with poor 90-day outcome (CHG: OR 1.31 per SD, 95% CI 1.07–1.61; RCII: OR 1.23 per SD, 95% CI 1.04–1.46) and poor discharge outcome. The highest RCII quartile exhibited more than threefold increased odds of a poor 90-day outcome (OR 3.43, 95% CI 1.90–6.20). Both indices were associated with larger lesion size, and RCII was additionally associated with hemorrhagic transformation (Q4 vs. Q1: OR 2.42, 95% CI 1.23–4.75). Restricted cubic spline analyses demonstrated no evidence of non-linearity. Adding RCII to a base clinical model significantly improved discrimination (AUC 0.645 vs. 0.564, DeLong p = 0.004). No significant sex interaction was observed; RCII showed significant interactions with age and TOAST subtype. Conclusions: Both CHG and RCII indices are independently associated with poor functional outcomes, larger infarct size, and—for RCII—hemorrhagic transformation in young patients with acute ischemic stroke. These readily calculable biomarkers may provide complementary prognostic information in this population, though their clinical utility requires further prospective validation.
Full article
(This article belongs to the Topic Biomarker Development and Application, 2nd Edition)
►▼
Show Figures

Figure 1
Open AccessArticle
Timing of Great Saphenous Vein Assessment Influences Vein Caliber Before CABG
by
Ömer Faruk Rahman, Selim Durmaz, Tünay Kurtoğlu, Fevzi Ayyıldız, Meryem Nil Kaan and Berent Dişcigil
J. Clin. Med. 2026, 15(11), 4326; https://doi.org/10.3390/jcm15114326 (registering DOI) - 3 Jun 2026
Abstract
Background: Preoperative ultrasonographic mapping of the great saphenous vein (GSV) is a valuable tool for improving assessment of vein caliber during surgical planning. However, current data are insufficient to establish clear standards for optimal anatomical evaluation. The aim of this study was
[...] Read more.
Background: Preoperative ultrasonographic mapping of the great saphenous vein (GSV) is a valuable tool for improving assessment of vein caliber during surgical planning. However, current data are insufficient to establish clear standards for optimal anatomical evaluation. The aim of this study was to investigate the effect of anesthetic induction on GSV caliber in patients undergoing CABG. Methods: In this retrospective study, the diameter of the GSV was measured using ultrasonography at predefined anatomical landmarks during the pre- and post-induction periods in patients undergoing CABG, and the obtained values were compared. Results: A total of 59 patients were included. A significant increase in the GSV diameter was observed after anesthetic induction in all segments (all p < 0.001). The median diameters increased from 1.9 to 2.7 mm in the distal segment, from 1.6 to 2.4 mm in the mid segment, and from 2.3 to 3.4 mm in the proximal segment. The percentage change in diameter after anesthetic induction was comparable across all measured segments (p = 0.888). The pre-induction diameter was strongly and negatively correlated with the percentage diameter change in all segments (all p < 0.001), and this association remained significant after controlling for the post-induction diameter (all p < 0.001). Conclusions: In this study, the ultrasonographic assessment timing was found to significantly influence GSV caliber evaluation in patients undergoing CABG. Anesthetic induction was associated with a significant and consistent increase in saphenous vein diameter across all measured segments, suggesting that anesthetic status may influence ultrasound-based vein mapping and conduit assessment. Further prospective studies incorporating clinical outcome measures and conduit suitability assessment are needed to better clarify the clinical implications of these findings.
Full article
(This article belongs to the Section Vascular Medicine)
►▼
Show Figures

Figure 1
Open AccessSystematic Review
Hearing Outcomes Following Ventriculoperitoneal Shunt Placement: A Scoping Review
by
Mukta Vibhute, Rachel Zhang, Anna Bareiss, Andrew R. Mangan, Kenny Nguyen, Emily Goodman, John Dornhoffer and Robert A. Saadi
J. Clin. Med. 2026, 15(11), 4325; https://doi.org/10.3390/jcm15114325 (registering DOI) - 3 Jun 2026
Abstract
Background/Objectives: Ventriculoperitoneal shunt (VPS) placement alters cerebrospinal (CSF) dynamics and has been associated with hearing changes through pressure transmission via the cochlear aqueduct. Despite the large number of patients undergoing VPS placement annually, associated hearing changes remain poorly characterized. This scoping review
[...] Read more.
Background/Objectives: Ventriculoperitoneal shunt (VPS) placement alters cerebrospinal (CSF) dynamics and has been associated with hearing changes through pressure transmission via the cochlear aqueduct. Despite the large number of patients undergoing VPS placement annually, associated hearing changes remain poorly characterized. This scoping review aimed to characterize the available evidence on hearing outcomes following VPS placement and identify gaps warranting further investigation. Methods: This scoping review was conducted in accordance with PRISMA-ScR guidelines. PubMed was queried from January 1980 through January 2026. Eligible studies included case reports, case series, and observational cohorts reporting hearing outcomes following VPS placement. Two independent reviewers screened titles, abstracts, and full texts. Risk of bias was assessed using Joanna Briggs critical appraisal tools. Due to heterogeneity in study designs, outcomes metrics, and follow-up duration, quantitative synthesis was not performed. Results: Nineteen studies comprising approximately 200 patients met inclusion criteria. Hearing deterioration and improvement were each reported in 7 studies (36.8%); mixed outcomes were reported in 5 studies (26.3%). Acute hearing changes occurred within 48 h in 3 studies (15.8%), whereas delayed changes were described in 13 studies (68.4%). Overall quality of evidence was low. Conclusions: This scoping review identifies VPS placement as a clinically underrecognized contributor to hearing change. Current evidence is heterogenous and dominated by low level studies, underscoring the need for prospective investigation with standardized audiologic protocols. Preoperative audiograms should be considered when possible, as well as a low threshold for audiology referral for postoperative hearing concerns.
Full article
(This article belongs to the Special Issue Diagnosis and Treatment for Hearing Loss: Expert Views)
►▼
Show Figures

Figure 1
Open AccessArticle
Association of Baseline Femoral Trochlear T2* Mapping with Clinical Response to Platelet-Rich Plasma in Patellofemoral Chondropathy: A Retrospective Exploratory Study
by
Carla Fuster Such, Francisco Lajara-Marco, Jorge Salvador-Marín, Vicente J. León-Muñoz and María Francisca Cegarra-Navarro
J. Clin. Med. 2026, 15(11), 4324; https://doi.org/10.3390/jcm15114324 (registering DOI) - 3 Jun 2026
Abstract
Background: Platelet-rich plasma (PRP) is utilised in the treatment of patellofemoral chondropathy, although clinical responses remain variable. This retrospective exploratory study assessed whether baseline quantitative T2* mapping of femoral cartilage was associated with clinical improvement following PRP administration. Methods: In this retrospective observational
[...] Read more.
Background: Platelet-rich plasma (PRP) is utilised in the treatment of patellofemoral chondropathy, although clinical responses remain variable. This retrospective exploratory study assessed whether baseline quantitative T2* mapping of femoral cartilage was associated with clinical improvement following PRP administration. Methods: In this retrospective observational study conducted within routine clinical practice, patients with patellofemoral chondropathy received three ultrasound-guided intra-articular PRP injections administered weekly according to an institutional protocol. Baseline and 9-month T2*-mapping MRI scans and clinical questionnaires were collected as part of standard follow-up. The main imaging variable was the worst-region femoral trochlear T2* value, evaluated as a candidate prognostic biomarker. Clinical outcomes included the Visual Analogue Scale (VAS, 0–10) and Kujala (0–100) scores, with responders defined by minimum clinically important difference (MCID) thresholds (ΔVAS ≥ 1.5; ΔKujala ≥ 8). Results: Thirty-two knees from 22 patients completed follow-up, including 10 bilateral cases (19 right knees, 13 left knees). Both VAS and Kujala scores improved significantly at 9 months (p < 0.001 for both). Baseline femoral trochlear worst-region T2* values were inversely correlated with pain and functional improvement (ΔVAS: rho = −0.51, p = 0.003; ΔKujala: rho = −0.36, p = 0.042). Baseline patellar T2* values were not associated with clinical change (ΔVAS: rho = −0.18, p = 0.32; ΔKujala: rho = −0.12, p = 0.51). Sensitivity analyses using baseline mean femoral T2* values did not show significant associations with ΔVAS or ΔKujala. Interobserver reproducibility for the worst-region T2* metric was limited, particularly for the femoral compartment (femur ICC 0.37; patella ICC 0.47), which limits immediate clinical applicability. Mean regional longitudinal ΔT2* changes did not exceed the 14% QIBA MDC95 threshold. Conclusions: In this small retrospective cohort, baseline femoral trochlear worst-region T2* values were associated with clinical improvement after PRP. These preliminary hypothesis-generating findings should be interpreted with caution and require validation in larger controlled cohorts with standardised and reproducible segmentation workflows.
Full article
(This article belongs to the Section Sports Medicine)
►▼
Show Figures

Figure 1
Open AccessArticle
Estimation of Intradialytic Blood Volume Reduction Using Hemoglobin Changes: A Prospective Validation Study of a Pragmatic Clinical Tool
by
Nomy Levin Iaina, Muhamed Osman, Fadi Garzuzi, Sergey Bellov and Arie Feldman
J. Clin. Med. 2026, 15(11), 4323; https://doi.org/10.3390/jcm15114323 (registering DOI) - 3 Jun 2026
Abstract
Background/Objectives: Accurate assessment of intradialytic blood volume (BV) changes is important for optimizing fluid management in hemodialysis, but continuous BV monitoring is not universally available. Hemoglobin changes reflect hemoconcentration and may provide a simple surrogate for estimating BV reduction. We prospectively evaluated a
[...] Read more.
Background/Objectives: Accurate assessment of intradialytic blood volume (BV) changes is important for optimizing fluid management in hemodialysis, but continuous BV monitoring is not universally available. Hemoglobin changes reflect hemoconcentration and may provide a simple surrogate for estimating BV reduction. We prospectively evaluated a hemoglobin-based method for estimating intradialytic BV reduction compared with machine-based BV monitoring. Methods: In this prospective single-center observational study, 187 hemodialysis sessions with complete paired measurements were analyzed. Formula-based BV reduction was calculated from pre- and post-dialysis hemoglobin values and compared with machine-measured BV reduction. Agreement was assessed using Pearson correlation, predefined absolute-difference thresholds, and Bland–Altman analysis. Exploratory receiver operating characteristic analyses evaluated the ability of formula-based estimates to identify sessions with larger machine-measured BV reductions. Results: Formula-based and machine-measured BV reduction demonstrated a moderate-to-strong correlation (r = 0.645). The predefined pragmatic agreement criterion of ≥70% of measurements within ±5% was met, with 77.5% of measurements within this range. Bland–Altman analysis demonstrated a small mean bias of −1.5%, with 95% limits of agreement from −12.4% to 9.3%. Exploratory classification performance was favorable across machine-defined BV reduction thresholds, with area under curve (AUC) values ranging from 0.84 to 0.87. At the ≥8% threshold, sensitivity was 72%, specificity 85%, positive predictive value 83%, and negative predictive value 74%. Linear regression showed that 42% of variability in machine-measured BV reduction was explained by the formula-based estimate. Conclusions: A hemoglobin-based approach provides a simple approximation of intradialytic BV reduction. Although not interchangeable with continuous monitoring, it may support post-session assessment and longitudinal evaluation of intradialytic hemodynamic tolerance.
Full article
(This article belongs to the Special Issue Peritoneal Dialysis and Hemodialysis: Early and Late Outcomes)
►▼
Show Figures

Figure 1
Open AccessArticle
Association Between the COGAS Score and Delayed Neuropsychiatric Sequelae After Acute Carbon Monoxide Poisoning
by
Sun Chul Lee and Gyo Jin Ahn
J. Clin. Med. 2026, 15(11), 4322; https://doi.org/10.3390/jcm15114322 (registering DOI) - 3 Jun 2026
Abstract
Background/Objectives: Carbon monoxide (CO) poisoning remains a major cause of poisoning-related morbidity, and delayed neuropsychiatric sequelae (DNS) are important long-term complications. This study evaluated the association between the COGAS score and operationally defined 6-month DNS after acute CO poisoning. Methods: Overall,
[...] Read more.
Background/Objectives: Carbon monoxide (CO) poisoning remains a major cause of poisoning-related morbidity, and delayed neuropsychiatric sequelae (DNS) are important long-term complications. This study evaluated the association between the COGAS score and operationally defined 6-month DNS after acute CO poisoning. Methods: Overall, 272 patients with acute CO poisoning were included in this single-center observational cohort study. The primary outcome was operationally defined as 6-month DNS based on changes in the Global Deterioration Scale (GDS). Logistic regression analyses were performed to evaluate the association between the COGAS score and operationally defined 6-month DNS. Conventional and Firth penalized logistic regression models were used. Results: Among 272 patients, 14 (5.1%) met the criteria for operationally defined 6-month DNS. Each 1-point increase in the COGAS score was associated with higher odds of operationally defined 6-month DNS in univariable analysis (odds ratio [OR], 2.16; 95% confidence interval [CI], 1.30–3.65; p = 0.003) and in the fully adjusted model including initial GDS, troponin I, and CO exposure duration (OR, 2.19; 95% CI, 1.14–4.35; p = 0.020). Conclusions: Higher COGAS scores were associated with operationally defined 6-month DNS after acute CO poisoning. The COGAS score may provide prognostic information, but further validation in larger cohorts is needed.
Full article
(This article belongs to the Section Emergency Medicine)
►▼
Show Figures

Figure 1
Open AccessArticle
Perioperative Anesthetic Factors and Flap Outcome in Pediatric Head and Neck Free Flap Reconstruction: A Retrospective Study
by
Dominika Lech, Robert Maksymowicz, Jeremi Matysek, Cyprian Strączek, Michalina Ceroń, Marcin Kozakiewicz, Łukasz Krakowczyk and Krzysztof Dowgierd
J. Clin. Med. 2026, 15(11), 4321; https://doi.org/10.3390/jcm15114321 - 3 Jun 2026
Abstract
Background: Microvascular free flap reconstruction is an established method for the management of complex head and neck defects in pediatric patients. However, the influence of perioperative anesthetic management on flap outcome in this population remains insufficiently defined. The aim of this study was
[...] Read more.
Background: Microvascular free flap reconstruction is an established method for the management of complex head and neck defects in pediatric patients. However, the influence of perioperative anesthetic management on flap outcome in this population remains insufficiently defined. The aim of this study was to evaluate the association between selected perioperative anesthetic factors and flap outcome in pediatric patients. Methods: This retrospective observational study included pediatric patients undergoing microvascular free flap reconstruction between August 2011 and July 2020. Of 80 screened patients, 56 met the inclusion criteria based on complete medical records. Demographic, surgical, and perioperative anesthetic variables were collected. Continuous variables were compared using the Mann–Whitney U test, and categorical variables using the chi-squared test with Yates’ correction. Correction for multiple testing was performed using the Benjamini–Hochberg false discovery rate procedure. Results: Complete flap survival was achieved in 50 patients (89.3%), while partial and total flap loss occurred in 3 patients each (5.4%). No significant associations with flap loss were identified for the type of anesthetic gas, opioid use, induction agents, intraoperative fluid therapy, diuresis, rocuronium dose, or operation time. Lower weight-adjusted doses of midazolam and propofol showed borderline unadjusted associations with flap loss; however, these differences did not reach statistical significance after correction for multiple testing. Patients with flap loss had a higher mean intraoperative body temperature compared to those with successful flap survival (36.65 °C vs. 36.05 °C; p < 0.05). Conclusions: In pediatric head and neck free flap reconstruction, most analyzed perioperative anesthetic factors were not associated with flap outcome. Dose-related findings for midazolam and propofol should be interpreted as exploratory and non-significant after correction for multiple testing, while higher intraoperative body temperature was associated with flap loss. However, these results are exploratory, cannot establish causality, and require confirmation in larger, preferably multicenter studies with adjustment for surgical and patient-related confounders.
Full article
(This article belongs to the Section Plastic, Reconstructive and Aesthetic Surgery/Aesthetic Medicine)
►▼
Show Figures

Figure 1
Open AccessArticle
Diagnostic Performance of Artificial Intelligence Corrected OCT Measurements in Highly Myopic Eyes with Glaucoma
by
Patricia Robles Amor, Alfonso Antón López, Susana Duch Tuesta, Javier Moreno Montañés, Francisco José Muñoz Negrete, Ignacio Rodríguez Uña, Laura Morales Fernández, Federico Sáenz Francés, Julián García Feijoó, José María Martínez de la Casa and on behalf of GlaucoAI-Spain
J. Clin. Med. 2026, 15(11), 4320; https://doi.org/10.3390/jcm15114320 (registering DOI) - 3 Jun 2026
Abstract
Objectives: This study aimed to evaluate the diagnostic performance of peripapillary retinal nerve fiber layer (RNFL) thickness measurements corrected by artificial intelligence (AI) compared to original uncorrected values for glaucoma detection in highly myopic patients. Methods: This cross-sectional diagnostic accuracy study included 57
[...] Read more.
Objectives: This study aimed to evaluate the diagnostic performance of peripapillary retinal nerve fiber layer (RNFL) thickness measurements corrected by artificial intelligence (AI) compared to original uncorrected values for glaucoma detection in highly myopic patients. Methods: This cross-sectional diagnostic accuracy study included 57 eyes from highly myopic patients (31 with glaucoma, 26 without glaucoma). Peripapillary RNFL parameters were obtained using Spectralis optical coherence tomography (OCT). A deep learning algorithm (MGU-Net) was employed to automatically segment retinal layers and compensate for scan tilt in elongated eyes, producing AI-corrected measurements. RNFL thickness values were extracted for six sectoral parameters (ST, SN, N, IN, T, IT) and global. Diagnostic performance was assessed using area under the ROC curve (AUC) and compared between corrected and uncorrected values. Multivariable logistic regression models were also developed using stepwise selection. Results: AI-corrected values were significantly lower than original measurements in all sectors (p < 0.001), with mean differences ranging from 15 to 35 µm. In glaucomatous eyes, significant thinning was observed in the global (p = 0.049) and inferior nasal (IN) sector (p = 0.037) among corrected values. The highest AUCs were found in IN (0.69), IT (0.67), and global (0.66) for corrected values, and in IT (0.63), T (0.59), and global (0.63) for uncorrected data. A model combining ST, T, and IT AI-corrected values achieved an AUC of 0.79. Conclusions: AI-corrected RNFL thickness measurements improve consistency and enhance diagnostic performance in highly myopic glaucoma patients. Correction algorithms may reduce false positives and help reveal glaucomatous damage otherwise obscured by myopic anatomical changes.
Full article
(This article belongs to the Section Ophthalmology)
►▼
Show Figures

Figure 1
Open AccessArticle
Exocrine Pancreatic Insufficiency in Diabetes: Association with Cardiovascular Disease and Insulin Therapy
by
Melek Balamir, Bartu Avcı, Elara Coşan, Sinan Tanyolaç, Bilger Çavuş, Aslı Çifcibaşı Örmeci, Filiz Akyüz, Selman Fatih Beşışık, Sabahattin Kaymakoğlu, Hulya Hacısahinogullari, Göktuğ Sarıbeyliler, Ramazan Çakmak, Kubilay Karşıdağ, Şirin Çetin and Kadir Demir
J. Clin. Med. 2026, 15(11), 4319; https://doi.org/10.3390/jcm15114319 - 3 Jun 2026
Abstract
Background/Objectives: Exocrine pancreatic insufficiency (EPI) is increasingly recognized in patients with diabetes; however, its clinical correlates remain poorly defined. This study aimed to determine the prevalence and clinical characteristics of EPI in patients with type 1 (T1DM) and type 2 diabetes mellitus
[...] Read more.
Background/Objectives: Exocrine pancreatic insufficiency (EPI) is increasingly recognized in patients with diabetes; however, its clinical correlates remain poorly defined. This study aimed to determine the prevalence and clinical characteristics of EPI in patients with type 1 (T1DM) and type 2 diabetes mellitus (T2DM) and to evaluate its associations with diabetes-related complications and insulin therapy. Methods: A total of 200 patients with diabetes were screened, and 182 who met the inclusion criteria were included in the final analysis. EPI was diagnosed using fecal elastase-1 (FE-1). Clinical, biochemical, and complication-related data were collected. Factors associated with EPI were evaluated using univariate and multivariate logistic regression analyses. Among patients with T2DM, an inverse probability of treatment weighting–average treatment effect on the treated (IPTW-ATT) model was constructed to evaluate the association between insulin therapy and EPI. Propensity scores were estimated using baseline demographic and clinical covariates, and covariate balance after weighting was assessed using standardized mean differences (SMDs). Results: Exocrine pancreatic insufficiency was detected in 18.1% of patients, with prevalences of 21.2% in T1DM and 17.4% in T2DM. Cardiovascular disease was the only variable independently associated with EPI in multivariate analysis (OR = 3.25; 95% CI: 1.12–6.75; p = 0.028. Among patients with T2DM, insulin therapy was significantly associated with EPI in both unadjusted and IPTW-ATT analyses (weighted OR = 10.76; 95% CI: 1.85–62.76; p = 0.008) with a wide confidence interval reflecting sparse data. Cardiovascular disease also remained significantly associated with EPI in the weighted model (OR = 3.52; 95% CI: 1.22–10.15; p = 0.020). Conclusions: Exocrine pancreatic insufficiency is a clinically relevant condition in diabetes and shows a significant cross-sectional association with cardiovascular disease. In T2DM, insulin therapy was associated with a higher prevalence of EPI, although confounding by indication cannot be excluded. These findings suggest that evaluation of exocrine pancreatic function may be considered in high-risk diabetic subgroups, pending confirmation in prospective longitudinal studies.
Full article
(This article belongs to the Section Gastroenterology & Hepatopancreatobiliary Medicine)
Open AccessArticle
Baseline Functional Performance Predicts Better Long-Term Self-Reported Physical Function After Auto-HSCT
by
Lindsey J. Anderson, Lily Okamura, Nina Dhunjishah, Roshni Gowrisankar, Jennifer Song, Thomas R. Chauncey and Jose M. Garcia
J. Clin. Med. 2026, 15(11), 4318; https://doi.org/10.3390/jcm15114318 - 3 Jun 2026
Abstract
Background/Objectives: Determination of baseline predictors of longer-term quality of life (QOL) after autologous hematopoietic stem cell transplantation (Auto-HSCT) may identify patients with the greatest supportive care needs. We hypothesized that baseline older age, weight loss, and worse functional performance would negatively predict
[...] Read more.
Background/Objectives: Determination of baseline predictors of longer-term quality of life (QOL) after autologous hematopoietic stem cell transplantation (Auto-HSCT) may identify patients with the greatest supportive care needs. We hypothesized that baseline older age, weight loss, and worse functional performance would negatively predict QOL over two years post-HSCT. Methods: Physical function, body composition, and QOL were assessed before (PRE) and one month (1MO) after Auto-HSCT in U.S. Veterans (N = 23). QOL and survival were also assessed approximately every six months for two years after Auto-HSCT (5MO, 1YR, 1.5YR, and 2YR). Changes over time were tested via Generalized Estimating Equation regression analyses (p < 0.05 = significant). The impact of PRE variables on QOL at each follow-up was tested via Spearman’s correlations (p < 0.01 = significant). Results: Relative to PRE, depression and anxiety significantly improved (p ≤ 0.039) at 1MO while fatigue and vitality significantly worsened (p ≤ 0.024) 1MO to 5MO post-HSCT. Vitality, depression, and anxiety returned to PRE levels thereafter, while fatigue trajectory varied depending on the survey used. Bone-Marrow-Transplant-related QOL significantly improved at 5MO (p = 0.014) while self-reported function (p ≤ 0.021) and physical activity (p ≤ 0.045) significantly improved 1-2YR post-HSCT. Greater PRE 30 s chair stand test performance consistently correlated with better self-reported function 1-2YR (r = 0.76–0.91, p ≤ 0.007) post-HSCT. Greater PRE 6 min walk test performance consistently correlated with better symptom burden 1-2YR (r = 0.71–0.81, p ≤ 0.01) post-HSCT. Conclusions: In support of our hypothesis, baseline functional performance was associated with QOL during two years of recovery after Auto-HSCT; older age and recent weight loss at baseline only predicted worse baseline QOL. Our data indicates that evaluation of the 30 s chair stand and 6 min walk tests as rehabilitation targets and/or predictors of QOL, fitness, or mortality after Auto-HSCT are warranted. Larger, controlled studies are needed to confirm the findings from this exploratory analysis.
Full article
(This article belongs to the Special Issue Hematological Neoplasms: Diagnosis, Treatment, and Management in the Department of Veterans Affairs)
►▼
Show Figures

Figure 1
Open AccessArticle
Spectral Features of Heart Rate Variability in Williams Syndrome During Sleep
by
Bence Schneider, Ferenc Gombos, Ilona Kovács and Róbert Bódizs
J. Clin. Med. 2026, 15(11), 4317; https://doi.org/10.3390/jcm15114317 - 3 Jun 2026
Abstract
Background: This study analyzed spectral alterations of heart rate variability (HRV) in Williams syndrome (WS) during sleep, taking into account the multi-fractal properties of RR-interval spectra, including effects of aging and sleep structure. Methods: Using ECG recordings of 20 subjects with WS and
[...] Read more.
Background: This study analyzed spectral alterations of heart rate variability (HRV) in Williams syndrome (WS) during sleep, taking into account the multi-fractal properties of RR-interval spectra, including effects of aging and sleep structure. Methods: Using ECG recordings of 20 subjects with WS and matched typically developing (TD) controls, fractal and oscillatory spectral components of RR-intervals were computed. The fractal component was parametrized with a piecewise-linear function, allowing a breakpoint and separate slope and intercept values in the lower- and higher-frequency domains. The dominant peak frequency and prominence were extracted from the LF (0.04–0.15 Hz) and HF (0.15–0.4 Hz) bands. Results: Strong WS/TD group differences were found in the breakpoint frequency, high domain slope, intercept and HF peak prominence. The LF peak frequency showed a slight age-dependent decrease only in TD, and reduced values in WS independent of age. Principal component analysis identified a main fractal component describing typical alterations in the spectrum in WS, which exhibited sleep-structure associations. Conclusions: The broken power-law model successfully characterized the fractal component of RR-interval spectra, capturing altered cardiac regulation in WS, while suggesting the fractal parameters as possible biomarkers of the degree of general autonomic deregulation.
Full article
(This article belongs to the Special Issue Multifactorial Causation and Therapy of Sleep Disorders)
►▼
Show Figures

Figure 1
Open AccessArticle
Effectiveness and Cost Analysis of Implementation of Tele-ICU: A Multicenter Administrative Database Study Using Interrupted Time-Series Analysis Within a University-Affiliated Hospital Network
by
Kazuki Kikuyama, Hiroyuki Ohbe, Yumi Igarashi, Taro Watanabe, Maiko Mori, Toshikazu Abe and Toru Kotani
J. Clin. Med. 2026, 15(11), 4316; https://doi.org/10.3390/jcm15114316 - 3 Jun 2026
Abstract
Background: The telemedicine intensive care unit (tele-ICU) enables remote monitoring and support for intensive care unit (ICU) patients, connecting onsite care teams with remote critical care specialists through audio–video links and electronic data. While it has been shown to improve outcomes and reduce
[...] Read more.
Background: The telemedicine intensive care unit (tele-ICU) enables remote monitoring and support for intensive care unit (ICU) patients, connecting onsite care teams with remote critical care specialists through audio–video links and electronic data. While it has been shown to improve outcomes and reduce costs in the U.S., evidence on tele-ICU in Japan is limited. The present study aimed to investigate the effectiveness and cost of the implementation of tele-ICU in Japanese hospitals. Methods: This retrospective cohort study used administrative data from two Japanese hospitals where tele-ICU was implemented in April 2018. All adult patients admitted to the ICUs from April 2014 to March 2022 were included. Interrupted time-series analysis was conducted to compare trends in in-hospital mortality, complications, and hospitalization costs before and after tele-ICU implementation, with adjustments for baseline characteristics. Results: A total of 26,684 patients were included. Of these, 10,981 (41%) and 15,703 (59%) were before and after tele-ICU implementation, respectively. After tele-ICU implementation, there were significant downward level changes for in-hospital mortality (−2.62%; 95% confidence intervals −4.08 to −1.16%) and hospitalization costs (−221 thousand yen per patient; −412 to −29.7). A significant downward slope change was observed for complications (−1.82% per year; −2.54 to −1.09%). Subgroup analysis revealed that the mortality reduction was observed mainly in medium-severity, nonsurgery, and general ICU patients. Conclusions: Tele-ICU implementation was associated with lower in-hospital mortality, fewer complications, and lower hospitalization costs, particularly among medium-severity and nonsurgical patients. Further multicenter prospective studies are warranted.
Full article
(This article belongs to the Section Intensive Care)
►▼
Show Figures

Figure 1
Open AccessSystematic Review
Network Meta-Analysis of Cognitive Impairment and miRNA Expression in Alzheimer’s Disease Patients with Hearing Loss: A Systematic Review and Cross-Validation
by
Xin Wang and Cuibai Wei
J. Clin. Med. 2026, 15(11), 4315; https://doi.org/10.3390/jcm15114315 - 3 Jun 2026
Abstract
Background: Age-related hearing loss (HL) is a significant independent risk factor for Alzheimer’s disease (AD), yet the molecular mechanisms underlying this comorbidity and the comparative efficacy of hearing interventions for cognitive outcomes remain unclear. This study aims to integrate clinical evidence and molecular
[...] Read more.
Background: Age-related hearing loss (HL) is a significant independent risk factor for Alzheimer’s disease (AD), yet the molecular mechanisms underlying this comorbidity and the comparative efficacy of hearing interventions for cognitive outcomes remain unclear. This study aims to integrate clinical evidence and molecular data to address these gaps. Objective: The objective of this study was to conduct a systematic review and network meta-analysis (NMA) in order to: (1) compare the effects of hearing interventions on cognitive function in AD patients; (2) identify and rank key microRNAs (miRNAs) associated with AD-HL comorbidity; (3) explore heterogeneity sources; and (4) cross-validate findings with internal clinical sequencing data. Methods: We systematically searched PubMed, Web of Science, Embase, and the Cochrane Library, with a cut-off date of May 2024. Included studies involved AD patients with/without HL, reporting cognitive scores (MoCA, MMSE, and AVLT) or miRNA expression data. An NMA was performed to rank interventions (cochlear implants—CIs, hearing aids—HAs, and no intervention—NI) and miRNAs using surface under the cumulative ranking (SUCRA) curves. Heterogeneity was assessed via subgroup analysis and meta-regression. Pooled miRNA expression results were cross-validated against an internal clinical sequencing dataset (LC-P20240110033, n = 16) using the intraclass correlation coefficient (ICC) and Bland–Altman plots. Results: Twelve studies (2137 patients) were included. HL was significantly associated with worse cognitive function (MoCA: SMD = −0.82, 95% CI: −1.15 to −0.49; AVLT delayed recall: SMD = −1.12, 95% CI: −1.56 to −0.68). NMA revealed that the CI group (SUCRA = 0.89) was superior to the HA group (SUCRA = 0.62) and NI (SUCRA = 0.09) for preserving MoCA scores. Among the nine differentially expressed miRNAs identified in exploratory synthesis, three met strict quantitative criteria for NMA (reported in ≥2 independent studies with comparable quantification and variance data); hsa-miR-6875-5p was the most consistent biomarker (pooled FC = 1.52, 95% CI: 1.04–2.23), showing excellent agreement with sequencing data (FC = 3.29; ICC = 0.82, 95% CI: 0.67–0.91). Heterogeneity was significantly influenced by the miRNA detection platform (p = 0.04) and HL severity (p = 0.03). Conclusions: This study demonstrates that HL exacerbates cognitive decline in AD in a dose-dependent manner. Cochlear implants may offer superior cognitive protection compared to hearing aids. The consistently dysregulated hsa-miR-6875-5p emerges as a hypothesis-generating cross-modal biomarker, bridging clinical observation and molecular pathology in AD-HL comorbidity.
Full article
(This article belongs to the Section Clinical Neurology)
►▼
Show Figures

Figure 1
Open AccessSystematic Review
Early Childhood Caries and Oral Health-Related Quality of Life in Preschool Children: A Systematic Review
by
Paula Piekoszewska-Ziętek, Anna Turska-Szybka, Aleksandra Szczepanik and Dorota Olczak-Kowalczyk
J. Clin. Med. 2026, 15(11), 4314; https://doi.org/10.3390/jcm15114314 - 2 Jun 2026
Abstract
Objectives: To systematically review the evidence on the association between early childhood caries (ECC) and oral health-related quality of life (OHRQoL) in preschool children, focusing on studies using the Early Childhood Oral Health Impact Scale (ECOHIS) or its validated language versions. Methods
[...] Read more.
Objectives: To systematically review the evidence on the association between early childhood caries (ECC) and oral health-related quality of life (OHRQoL) in preschool children, focusing on studies using the Early Childhood Oral Health Impact Scale (ECOHIS) or its validated language versions. Methods: This systematic review was conducted and reported in accordance with the PRISMA 2020 guidelines. Electronic searches identified primary observational studies published within the last 10 years. Eligible studies included preschool children, clinically assessed ECC/caries, and OHRQoL measured with ECOHIS or a validated, adapted version. Data extraction covered study characteristics, caries assessment, OHRQoL measures, and main findings. Risk of bias was assessed using the Joanna Briggs Institute appraisal tools. Results: Twenty studies were included (19 cross-sectional and 1 cohort) with sample sizes ranging from 151 to 1783 participants. Across diverse populations and settings, ECC was consistently associated with poorer OHRQoL in preschool children and their families. Greater caries severity, untreated lesions, and advanced disease consequences were generally linked to higher ECOHIS scores. The most affected domains were pain, eating and drinking difficulties, sleep disturbance, irritability, and family distress. Conclusions: The available evidence consistently indicates that ECC is associated with poorer OHRQoL in preschool children and their families. From a clinical perspective, incorporating OHRQoL measures into pediatric dental assessment may improve recognition of disease burden beyond clinical indices alone.
Full article
(This article belongs to the Special Issue Pediatric Dentistry: Recent Advances, Current Issues and Future Challenges)
►▼
Show Figures

Figure 1
Open AccessArticle
Active Range of Motion in Non-Impingement Directions After Hip Arthroscopy for Femoroacetabular Impingement Syndrome
by
Łukasz Stołowski, Gino Kerkhoffs and Tomasz Piontek
J. Clin. Med. 2026, 15(11), 4313; https://doi.org/10.3390/jcm15114313 - 2 Jun 2026
Abstract
Background: Femoroacetabular impingement syndrome (FAIS) is a common cause of hip pain and functional limitation in young and physically active individuals. Although hip arthroscopy is an established treatment when conservative management fails, objective data on early postoperative changes in active hip range
[...] Read more.
Background: Femoroacetabular impingement syndrome (FAIS) is a common cause of hip pain and functional limitation in young and physically active individuals. Although hip arthroscopy is an established treatment when conservative management fails, objective data on early postoperative changes in active hip range of motion (ROM) remain limited. This study aimed to evaluate changes in active hip ROM three months after arthroscopic treatment for FAIS using inertial measurement units (IMUs) and to investigate their relationship with patient-reported outcomes. Methods: A prospective cohort of forty-two patients (mean age 36 ± 9 years; 64% male) undergoing hip arthroscopy for FAIS was assessed preoperatively and at a three-month follow-up. Active hip ROM—including flexion, internal rotation, external rotation, and total rotation—was measured using IMU sensors, while subjective outcomes were evaluated using the Hip disability and Osteoarthritis Outcome Score (HOOS). Results: Significant improvements were observed across all HOOS subscales at follow-up (all p < 0.001). The HOOS Total score increased from 57 ± 15 to 83 ± 11. Clinical recovery, defined by the Minimal Important Change (MIC), was achieved by 74% of patients for Symptoms, 81% for Pain, 81% for ADL, 83% for Sport, and 67% for Quality of Life (QOL). Active hip ROM in the operated hip increased significantly for internal rotation (19.6° ± 11.9° to 26° ± 8°), external rotation (37° ± 10° to 40° ± 8°), and total rotation (57° ± 15° to 67° ± 12°). Changes in hip flexion were not clinically meaningful (98° to 100°), and no changes were observed in the non-operated hip. Spearman’s analysis showed weak and inconsistent correlations between active ROM and HOOSs (r ranging from −0.34 to 0.31). Conclusions: Hip arthroscopy for FAIS leads to early improvements in both patient-reported outcomes and active hip mobility, particularly in rotational movements, although the relationship between ROM and subjective outcomes appears weak.
Full article
(This article belongs to the Special Issue New Advances in Hip and Knee Reconstructive Surgery: 2nd Edition)
Open AccessArticle
Orthodontic Need Among Adult Patients Seeking Oral Rehabilitation in Craiova
by
Amelia Smaranda Roșianu, Antonia Samia Khaddour, Emma Cristina Drăghici, Cosmin Mihai Mirițoiu, Ionela Elisabeta Staicu, Stelian Mihai Sever Petrescu, Răzvan Mercuț, Ionuț Cristian Resceanu, Alin Gabriel Ionescu and Sanda Mihaela Popescu
J. Clin. Med. 2026, 15(11), 4312; https://doi.org/10.3390/jcm15114312 - 2 Jun 2026
Abstract
Background/Objectives: The aim of the study was to determine the prevalence of molar absence and the need for limited preprosthetic orthodontic treatment in the situation of lateral molar edentulism in adult patients. Methods: The need for orthodontic treatment was studied retrospectively
[...] Read more.
Background/Objectives: The aim of the study was to determine the prevalence of molar absence and the need for limited preprosthetic orthodontic treatment in the situation of lateral molar edentulism in adult patients. Methods: The need for orthodontic treatment was studied retrospectively in a cohort of adult patients of both genders who presented for dental treatment at the Oral Rehabilitation Clinic of the University of Medicine and Pharmacy of Craiova. After applying the inclusion/exclusion criteria, the final study group consisted of 478 patients. The collected data were centralized in Microsoft Excel and statistical analyses were performed using SPSS software version 26. Results: The results of the study showed that more than 50% of adult patients need orthodontic treatment. The patients with the greatest need for orthodontic treatment also had a higher DMFT (p < 0.0005), indicating a higher need for dental caries treatment, as well as prosthetics of edentulous areas. The prevalence of molar edentulism was 57.31%. The acceptance of the treatment plan was inversely proportional to the need for orthodontic treatment. Tooth wear (p < 0.0005) and maxillary edentulism (p = 0.002) significantly contributed to a higher DAI. Conclusions: The need for orthodontic treatment increases with age, but the acceptance of oral rehabilitation plans that include orthodontic treatment is low. Better interdisciplinary collaboration is needed to ensure that adult patients benefit from the best treatment options.
Full article
(This article belongs to the Special Issue Orthodontics: State of the Art and Perspectives)
Open AccessArticle
Molecular Evaluation of RNA-Based Immune Checkpoint Profiling in Clear Cell Renal Cell Carcinoma
by
Erica Giacobbi, Valeria Palumbo, Francesca Servadei, Rita Bonfiglio, Giusella Maria Francesca Moscato, Marco Carilli, Matteo Vittori, Valerio Iacovelli, Pierluigi Bove, Alessandro Mauriello and Manuel Scimeca
J. Clin. Med. 2026, 15(11), 4311; https://doi.org/10.3390/jcm15114311 - 2 Jun 2026
Abstract
Background: Clear cell renal cell carcinoma is considered an immunologically “hot” tumor, with an abundance of tumor-infiltrating immune cells. This feature has a strong effect on therapeutic outcomes, especially in immune therapies. Within this context, immune checkpoint expression plays a central role in
[...] Read more.
Background: Clear cell renal cell carcinoma is considered an immunologically “hot” tumor, with an abundance of tumor-infiltrating immune cells. This feature has a strong effect on therapeutic outcomes, especially in immune therapies. Within this context, immune checkpoint expression plays a central role in RCC immunotherapy, establishing new standards of care for patients with advanced RCC. However, most patients do not derive the maximum benefit from immune checkpoint inhibitors and may experience severe adverse effects. This may highlight the need to better understand the complexity of immunosuppressive mechanisms within the tumor microenvironment, which involves a variety of molecules. As such, this study aims to characterize the immune checkpoint status by investigating the co-expression (RNASeq) of the main checkpoints in a cohort of 16 ccRCC. Results: In the investigated cohort, the evaluation of immune checkpoint molecules revealed the complexity of immune regulatory mechanisms within the tumor microenvironment. The marked heterogeneity in the expression of eight major immune checkpoint actors, namely, PD1, PDL1, CTLA4, PDL2, VISTA, TIM3, TIGIT, and LAG3, is matched by multiple co-expressed immune checkpoint molecules, making the immune checkpoint burden score. Specifically, immune-cold tumors displayed the highest degree of co-expression, together with high levels of PDL2 and VISTA. Furthermore, the expression of immune checkpoints, both individually and collectively, was positively associated with intratumoral immune cytolytic activity, highlighting the coexistence of immune activation and immune suppression as tightly interconnected processes. Conclusions: The data presented here supports the concept that a ccRCC microenvironment may be driven by multiple modulatory mechanisms that allow immune escape to happen. Revealing the coordination of immune checkpoint molecules and the compensatory upregulation mechanisms may support future studies exploring multi-target immunotherapeutic strategies.
Full article
(This article belongs to the Special Issue Urologic Oncology: From Diagnosis to Treatment)
►▼
Show Figures

Figure 1
Open AccessSystematic Review
Management of the Clinically N0 Neck in Maxillary Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
by
Fabio Maglitto, Giovanni Salzano, Serena Trotta, Eutilia Manzo, Luigi Angelo Vaira, Umberto Committeri, Stefania Troise and Giovanni Dell’Aversana Orabona
J. Clin. Med. 2026, 15(11), 4310; https://doi.org/10.3390/jcm15114310 - 2 Jun 2026
Abstract
Background: The optimal management of the clinically node-negative (cN0) neck in maxillary squamous cell carcinoma (MSCC) remains controversial due to the relatively low yet clinically relevant risk of occult cervical metastasis. While elective neck dissection (END) has been proposed to improve oncologic outcomes,
[...] Read more.
Background: The optimal management of the clinically node-negative (cN0) neck in maxillary squamous cell carcinoma (MSCC) remains controversial due to the relatively low yet clinically relevant risk of occult cervical metastasis. While elective neck dissection (END) has been proposed to improve oncologic outcomes, others advocate observation to avoid overtreatment. This study aimed to evaluate the impact of END versus observation on overall survival (OS) in cN0 MSCC patients. Methods: A systematic literature search was conducted in PubMed, Embase, and Scopus according to the PRISMA 2020 statement. The protocol was registered in PROSPERO (CRD420261345038). Studies including patients with maxillary SCC and clinically N0 neck comparing END with observation were eligible. Fourteen studies were included in the qualitative synthesis, and five were suitable for quantitative meta-analysis. The primary endpoint was OS. Pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated using a random-effects model. Risk of bias was assessed using ROBINS-I, and certainty of evidence was evaluated using the GRADE framework. Results: The meta-analysis demonstrated a statistically significant survival benefit associated with END. The pooled HR for OS was 0.76 (95% CI 0.67–0.86; p < 0.001), indicating a 24% relative reduction in the hazard of death compared with observation. Importantly, statistical heterogeneity was negligible (I2 = 0%), although interpretation should be cautious given the limited number of included studies. Despite this, most included studies were retrospective in design. Conclusions: END appears to provide a survival advantage in selected patients with cN0 MSCC. However, the evidence is largely derived from retrospective data. High-quality prospective multicenter studies are needed to better define the role of elective neck management in this population.
Full article
(This article belongs to the Special Issue New Technologies for Personalized Medicine in Head and Neck Surgery)
Journal Menu
► ▼ Journal Menu-
- JCM Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserHighly Accessed Articles
Latest Books
E-Mail Alert
News
1 June 2026
Journal of Clinical Medicine Webinar | When Stroke Hides: A Case-Based Journey Through Atypical Presentations and Complex Decisions in Acute Ischemic Stroke, 9 June 2026
Journal of Clinical Medicine Webinar | When Stroke Hides: A Case-Based Journey Through Atypical Presentations and Complex Decisions in Acute Ischemic Stroke, 9 June 2026
1 June 2026
Meet Us at the 22nd International Congress of Endocrinology, 2–5 June 2026, Kyoto, Japan
Meet Us at the 22nd International Congress of Endocrinology, 2–5 June 2026, Kyoto, Japan
Topics
Topic in
Cells, JCM, Organoids, JMP
Novel Discoveries in Oncology 2nd Edition
Topic Editors: Michela Campolo, Giovanna Casili, Alessia Filippone, Marika LanzaDeadline: 20 June 2026
Topic in
Biomedicines, IJMS, JCM, Medicina, Neurology International
Advances in Exercise-Induced Neurogenesis, Neuronal and Functional Adaptations in Neurorehabilitation
Topic Editors: Carlos Bernal-Utrera, Cleofas Rodriguez-Blanco, Maria Livia Carrascal MorenoDeadline: 29 June 2026
Topic in
Dentistry Journal, IJMS, JCM, Medicina, Applied Sciences
Oral Health Management and Disease Treatment
Topic Editors: Christos Rahiotis, Felice Lorusso, Sergio Rexhep TariDeadline: 31 July 2026
Topic in
Cancers, Diagnostics, Gastrointestinal Disorders, JCM, Current Oncology
Metastatic Colorectal Cancer: From Laboratory to Clinical Studies, 2nd Edition
Topic Editors: Ioannis Ntanasis-Stathopoulos, Diamantis I. TsilimigrasDeadline: 20 August 2026
Conferences
Special Issues
Special Issue in
JCM
Latest Research on Male Infertility
Guest Editor: Manesh Kumar Panner SelvamDeadline: 5 June 2026
Special Issue in
JCM
New Insights on Pharmacologic and Non-Pharmacologic Therapy of Advanced Heart Failure
Guest Editor: Michael DandelDeadline: 5 June 2026
Special Issue in
JCM
Orthodontics: State of the Art and Prospects
Guest Editors: Beatriz Tarazona-Álvarez, Natalia Zamora-MartínezDeadline: 5 June 2026
Special Issue in
JCM
Sjogren’s Syndrome: Clinical Advances and Insights
Guest Editor: David A. IsenbergDeadline: 7 June 2026
Topical Collections
Topical Collection in
JCM
Pediatric and Adolescent Gynecology
Collection Editor: Panagiotis Christopoulos



